Radiation Dose Optimisation Software Market By Component (Software, Automatic, Manual, Services, Education & Training, Support), End User (Hospitals, Diagnostic Centres, Cancer Research Institutes) & Region - Forecast to 2017 - 2027
Market Insights on Radiation Dose Optimisation Software covering sales outlook, demand forecast and up-to-date key trends
The focus of cancer treatment centres and hospitals for ensuring the safety of patients along with growing security concerns of workers working in radiation centres is encouraging end users such as hospitals to deploy radiation dose optimization software. Owing to this, vendors offering radiation dose optimisation software are continuously upgrading their product portfolios to meet the demands of the competitive radiation dose optimisation software market. The global radiation dose optimisation software market is expected to register significant growth in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Market Statistics
Details
H1,2021 (A)
27.1%
H1,2022 Projected (P)
27.4%
H1,2022 Outlook (O)
28.0%
BPS Change : H1,2022 (O) - H1,2022 (P)
(+) 60 ↑
BPS Change : H1,2022 (O) - H1,2021 (A)
(+) 90 ↑
The concentration of cancer cure hospitals for making sure the security of patients together with increasing the security of workers working in radiotherapy centres is promoting hospitals to set up radiation dose optimization software. Many vendors are providing radiation dose optimization software and are constantly improving their product offerings to become competitive in the radiation dose optimization software market.
According to the Future Market Insights analysis, the BPS values interpreted in the radiation dose optimization software market in H1,2022-(O) (Outlook) over H1,2022 (P) are projected to show a growth of +60 units. The reason for the growth of BPS values is the high focus on research and development in the healthcare sector, leading to higher adoption of modern technologies by healthcare providers is the major factor driving the market growth.
The BPS change: H1, 2022 (O) over H1,2021 (A) shows a growth of +90 units. The crucial reason for this growth of BPS values is a rise in the need for radiation dose optimization software in hospitals because of the growing number of medical X-ray imaging, computed tomography scans, and other diagnosis carried out in hospitals is the major factor driving the market growth.
Hospitals to emerge dominant in terms of deployment in the coming years
Radiation dose optimisation software is available in automatic as well as manual operating modes. The automatic mode is extensively favoured by end users such as diagnostic centres, hospitals, cancer research institutes, and others as it decreases errors that are likely to occur from human interference. The software solution automatically measures, examines, gathers, and reports a patient’s radiation exposure data in groups as well as on an individual basis, and also allows real-time staff exposure measurements.
Doctors are using radiation dose optimisation software for the purpose of observing and governing radiation doses in patients. Also, radiation dose optimisation software is used for controlling multiple aspects related to the dose. The radiation dose quantity varies as per the patient and the disease.
Given the humungous number of hospitals present in the world, the market for radiation dose optimisation software is expected to increase shortly. Moreover, the healthcare sector comprises a significant amount of market share in the global industry. Further, there is a high focus on research and development in the healthcare sector, leading to heavy adoption of the latest technologies by healthcare providers, which is expected to significantly impact the market growth of radiation dose optimisation software.
Hospitals are a key target area for radiation dose optimisation software vendors, accounting for over half the overall radiation dose optimisation software market. An increase in the demand for radiation dose optimisation software in hospitals is due to the increasing number of X-ray examinations, CT scans, and other examinations conducted in hospitals.
Diagnostic centres to provide lucrative opportunities in the near future
Diagnostic centres occupied a share of 22.0% in 2017 and are expected to witness a downfall in market share by the end of 2027. Despite witnessing a downfall, diagnostic centres will remain the second leading end user in terms of deployment of radiation dose optimisation software as the need to diagnose chronic diseases will trigger demand for the software. Cancer diagnosis will play a crucial role in the development of this sector in particular with radiation monitoring being the need of the hour.
Personalize your report by choosing insights you need and save 40%!
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Recommendations
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Radiation Dose Optimization Overview
2.4. Software Functionality
2.5. Comparison of Radiation Dose
2.6. Types of Dose Limits
2.7. Radiation Dose Management in Type of Modality
3. Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Value Chain Analysis
3.4. Key Regulations & Standards
4. Global Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
4.1. Market Value Projections
4.2. Market Size and Y-o-Y Growth
4.3. Absolute $ Opportunity
5. North America Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics and Impact Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Market Size (US$ Mn) By Country, 2012-2016
5.3.1. U.S.
5.3.2. Canada
5.4. Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
5.4.1. U.S.
5.4.2. Canada
5.5. Market Size (US$ Mn) and Opportunity Assessment By Component
5.5.1. Software
5.5.1.1. Automatic
5.5.1.2. Manual
5.5.2. Services
5.5.2.1. Education & Training
5.5.2.2. Support
5.6. Market Size (US$ Mn) and Opportunity Assessment By End User
5.6.1. Hospitals
5.6.2. Diagnostic Centers
5.6.3. Cancer Research Institutes
5.6.4. Others
5.7. Market Attractiveness Analysis
5.7.1. By Country
5.7.2. By Component
5.7.3. By End User
5.8. Market Presence (Intensity Map)
6. Western Europe Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics and Impact Analysis
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Market Size (US$ Mn) By Country, 2012-2016
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Spain
6.3.5. Italy
6.3.6. BENELUX
6.3.7. Nordic
6.3.8. Rest of Western Europe
6.4. Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Spain
6.4.5. Italy
6.4.6. BENELUX
6.4.7. Nordic
6.4.8. Rest of Western Europe
6.5. Market Size (US$ Mn) and Opportunity Assessment By Component
6.5.1. Software
6.5.1.1. Automatic
6.5.1.2. Manual
6.5.2. Services
6.5.2.1. Education & Training
6.5.2.2. Support
6.6. Market Size (US$ Mn) and Opportunity Assessment By End User
6.6.1. Hospitals
6.6.2. Diagnostic Centers
6.6.3. Cancer Research Institutes
6.6.4. Others
6.7. Market Attractiveness Analysis
6.7.1. By Country
6.7.2. By Component
6.7.3. By End User
6.8. Market Presence (Intensity Map)
7. Eastern Europe Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics and Impact Analysis
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Market Size (US$ Mn) By Country, 2012-2016
7.3.1. Russia
7.3.2. Poland
7.3.3. Rest of Eastern Europe
7.4. Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
7.4.1. Russia
7.4.2. Poland
7.4.3. Rest of Eastern Europe
7.5. Market Size (US$ Mn) and Opportunity Assessment By Component
7.5.1. Software
7.5.1.1. Automatic
7.5.1.2. Manual
7.5.2. Services
7.5.2.1. Education & Training
7.5.2.2. Support
7.6. Market Size (US$ Mn) and Opportunity Assessment By End User
7.6.1. Hospitals
7.6.2. Diagnostic Centers
7.6.3. Cancer Research Institutes
7.6.4. Others
7.7. Market Attractiveness Analysis
7.7.1. By Country
7.7.2. By Component
7.7.3. By End User
7.8. Market Presence (Intensity Map)
8. Latin America Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics and Impact Analysis
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Market Size (US$ Mn) By Country, 2012-2016
8.3.1. Brazil
8.3.2. Mexico
8.3.3. Rest of Latin America
8.4. Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Market Size (US$ Mn) and Opportunity Assessment By Component
8.5.1. Software
8.5.1.1. Automatic
8.5.1.2. Manual
8.5.2. Services
8.5.2.1. Education & Training
8.5.2.2. Support
8.6. Market Size (US$ Mn) and Opportunity Assessment By End User
8.6.1. Hospitals
8.6.2. Diagnostic Centers
8.6.3. Cancer Research Institutes
8.6.4. Others
8.7. Market Attractiveness Analysis
8.7.1. By Country
8.7.2. By Component
8.7.3. By End User
8.8. Market Presence (Intensity Map)
9. Japan Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
9.1. Introduction
9.2. Regional Market Dynamics and Impact Analysis
9.2.1. Drivers
9.2.2. Restraints
9.2.3. Trends
9.3. Market Size (US$ Mn) and Opportunity Assessment By Component
9.3.1. Software
9.3.1.1. Automatic
9.3.1.2. Manual
9.3.2. Services
9.3.2.1. Education & Training
9.3.2.2. Support
9.4. Market Size (US$ Mn) and Opportunity Assessment By End User
9.4.1. Hospitals
9.4.2. Diagnostic Centers
9.4.3. Cancer Research Institutes
9.4.4. Others
9.5. Market Attractiveness Analysis
9.5.1. By Component
9.5.2. By End User
9.6. Market Presence (Intensity Map)
10. Asia Pacific Excluding Japan (APEJ) Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
10.1.Introduction
10.2.Regional Market Dynamics and Impact Analysis
10.2.1. Drivers
10.2.2. Restraints
10.2.3. Trends
10.3.Market Size (US$ Mn) By Country, 2012-2016
10.3.1. China
10.3.2. India
10.3.3. Australia and New Zealand
10.3.4. ASEAN
10.3.5. Rest of APEJ
10.4.Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
10.4.1. China
10.4.2. India
10.4.3. Australia and New Zealand
10.4.4. ASEAN
10.4.5. Rest of APEJ
10.5.Market Size (US$ Mn) and Opportunity Assessment By Component
10.5.1. Software
10.5.1.1. Automatic
10.5.1.2. Manual
10.5.2. Services
10.5.2.1. Education & Training
10.5.2.2. Support
10.6.Market Size (US$ Mn) and Opportunity Assessment By End User
10.6.1. Hospitals
10.6.2. Diagnostic Centers
10.6.3. Cancer Research Institutes
10.6.4. Others
10.7.Market Attractiveness Analysis
10.7.1. By Country
10.7.2. By Component
10.7.3. By End User
10.8.Market Presence (Intensity Map)
11. Middle East and Africa Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
11.1.Introduction
11.2.Regional Market Dynamics and Impact Analysis
11.2.1. Drivers
11.2.2. Restraints
11.2.3. Trends
11.3.Market Size (US$ Mn) By Country, 2012-2016
11.3.1. GCC Countries
11.3.2. Turkey
11.3.3. Northern Africa
11.3.4. South Africa
11.3.5. Rest of MEA
11.4.Market Size (US$ Mn) and Opportunity Assessment By Country, 2017-2027
11.4.1. GCC Countries
11.4.2. Turkey
11.4.3. Northern Africa
11.4.4. South Africa
11.4.5. Rest of MEA
11.5.Market Size (US$ Mn) and Opportunity Assessment By Component
11.5.1. Software
11.5.1.1. Automatic
11.5.1.2. Manual
11.5.2. Services
11.5.2.1. Education & Training
11.5.2.2. Support
11.6.Market Size (US$ Mn) and Opportunity Assessment By End User
11.6.1. Hospitals
11.6.2. Diagnostic Centers
11.6.3. Cancer Research Institutes
11.6.4. Others
11.7.Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By Component
11.7.3. By End User
11.8.Market Presence (Intensity Map)
12. Forecast Factors: Relevance and Impact13. Competition Landscape
13.1.Market Structure
13.2.Market Share Analysis
13.3.Competition Intensity Mapping By Market Taxonomy
13.4.Competition Dashboard
13.5.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.5.1. General Electric Company
13.5.1.1. Revenue
13.5.1.2. Product Features
13.5.1.3. Company Highlights / Key Developments
13.5.1.4. Strategy Adopted
13.5.2. Koninklijke Philips N.V.
13.5.3. Siemens AG
13.5.4. Agfa-Gevaert Group
13.5.5. Bracco
13.5.6. Sectra AB
13.5.7. FUJIFILM Holdings Corporation
13.5.8. QAELUM NV
13.5.9. Virtual Phantoms Inc.
13.5.10. Medic Vision Imaging Solutions. Ltd.
13.5.11. Bayer AG
14. Global Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027
14.1.Introduction / Key Findings
14.2.Market Size (US$ Mn) and Opportunity Assessment By Region
14.2.1. North America
14.2.2. Western Europe
14.2.3. Eastern Europe
14.2.4. Latin America
14.2.5. Asia Pacific Excluding Japan
14.2.6. Middle East and Africa
14.3.Market Attractiveness Analysis By Region
15. Global Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027, By Component
15.1.Introduction
15.2.Market Size (US$ Mn) and Opportunity Assessment By Component
15.2.1. Software
15.2.1.1. Automatic
15.2.1.2. Manual
15.2.2. Services
15.2.2.1. Education & Training
15.2.2.2. Support
15.3.Market Attractiveness Analysis By component
16. Global Radiation Dose Optimization Software Market Analysis 2012–2016 and Opportunity Assessment 2017–2027, By End User
16.1.Introduction / Key Findings
16.2.Market Size (US$ Mn) and Opportunity Assessment By End User
16.2.1. Hospitals
16.2.2. Diagnostic Centers
16.2.3. Cancer Research Institutes
16.2.4. Others
16.3.Market Attractiveness Analysis By End User
17. Research Methodology18. Assumptions & Acronyms
